CAR-T cell therapy, a breakthrough treatment that has transformed certain cancer outcomes, is now showing early promise in tackling autoimmune diseases. In a recent case in Germany, a patient with multiple severe autoimmune conditions entered treatment-free remission after receiving the therapy, raising fresh questions about its potential beyond cancer.

In this episode, we break down how CAR-T works, why autoimmune diseases are so difficult to treat, and whether this approach could offer long-term remission or even a cure. We also look at the risks, costs and what this could mean for patients in India.